Fund Holdings — TYBOURNE CAPITAL MANAGEMENT (HK) LTD

Total Portfolio Value:
$30.93M
Total Bought:
$0
Total Sold:
$11.90M
Net Transaction:
-$11.90M
Securities
▲▼
SharesValue
Q2 2025
▲▼
Q3 2025
▲▼
Change
▲▼
Q2 2025
▲▼
Q3 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Taysha Gene Therapies, Inc.(TSHA)4,095,0003,700,000-395,000$9.46M$12.10M39.11%+$2.64M
Forte Biosciences Inc (Fbrx Us)786,647786,6470$10.17M$11.80M38.15%+$1.63M
Alumis Inc (Alms Us)1,399,2501,399,2500$4.20M$5.58M18.05%+$1.39M
Zentalis Pharmaceuticals, Inc.(ZNTL)1,478,152961,486-516,666$1.71M$1.45M4.69%-$262.8K
Bicycle Therapeutics Ltd-Adr (Bcyc Us)ADS993,7430-993,743$6.91M$0—-$6.91M
Malibu Boats, Inc.CL A(MBUU)66,7050-66,705$2.09M$0—-$2.09M
Page 1 of 1
TYBOURNE CAPITAL MANAGEMENT (HK) LTD — 13F Holdings — Q3 2025 | TickerTrail